{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:47:16Z","timestamp":1783982836623,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,16]]},"DOI":"10.7759\/cureus.22286","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T17:17:19Z","timestamp":1645031839000},"source":"Crossref","is-referenced-by-count":1,"title":["Medical Oncology or Surgical Oncology: Which Branch Should Be Started in Esophageal Cancer Diagnostic Evaluation?"],"prefix":"10.7759","author":[{"given":"\u00d6zgen Ahmet","family":"Y\u0131ld\u0131r\u0131m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkan","family":"Erdur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-020-01237-x","article-title":"Epidemiology of esophageal cancer: update in global trends, etiology and risk factors","volume":"13","author":"Uhlenhopp DJ","year":"2020","unstructured":"Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020, 13:1010-21. 10.1007\/s12328-020-01237-x","journal-title":"Clin J Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2016.10.005","article-title":"Esophageal cancer: risk factors, genetic association, and treatment","volume":"41","author":"Huang FL","year":"2018","unstructured":"Huang FL, Yu SJ. Esophageal cancer: risk factors, genetic association, and treatment. Asian J Surg. 2018, 41:210-5. 10.1016\/j.asjsur.2016.10.005","journal-title":"Asian J Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60643-6","article-title":"Oesophageal carcinoma","volume":"381","author":"Pennathur A","year":"2013","unstructured":"Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013, 381:400-12. 10.1016\/S0140-6736(12)60643-6","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002048","article-title":"Esophageal Cancer clinical presentation: trends in the last 3 decades in a large Italian series","volume":"267","author":"Cavallin F","year":"2018","unstructured":"Cavallin F, Scarpa M, Cagol M, et al.. Esophageal Cancer clinical presentation: trends in the last 3 decades in a large Italian series. Ann Surg. 2018, 267:99-104. 10.1097\/SLA.0000000000002048","journal-title":"Ann Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-10-173","article-title":"Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?","volume":"10","author":"Xu Y","year":"2012","unstructured":"Xu Y, Yu X, Chen Q, Mao W. Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?. World J Surg Oncol. 2012, 10:173. 10.1186\/1477-7819-10-173","journal-title":"World J Surg Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen P","year":"2012","unstructured":"van Hagen P, Hulshof MC, van Lanschot JJ, et al.. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012, 366:2074-84. 10.1056\/NEJMoa1112088","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000001954","article-title":"Utility of adjuvant chemotherapy after neoadjuvant chemoradiation and esophagectomy for esophageal cancer","volume":"266","author":"Burt BM","year":"2017","unstructured":"Burt BM, Groth SS, Sada YH, Farjah F, Cornwell L, Sugarbaker DJ, Massarweh NN. Utility of adjuvant chemotherapy after neoadjuvant chemoradiation and esophagectomy for esophageal cancer. Ann Surg. 2017, 266:297-304. 10.1097\/SLA.0000000000001954","journal-title":"Ann Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.semtcvs.2021.06.022","article-title":"Esophagectomy for esophageal cancer performed during the early phase of the COVID-19 pandemic [Online ahead of print]","author":"Dolan DP","year":"2021","unstructured":"Dolan DP, Swanson SJ, Lee DN, et al.. Esophagectomy for esophageal cancer performed during the early phase of the COVID-19 pandemic [Online ahead of print]. Semin Thorac Cardiovasc Surg. 2021, 10.1053\/j.semtcvs.2021.06.022","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-944847","article-title":"Delays in diagnosis and therapy of gastric cancer and esophageal adenocarcinoma","volume":"38","author":"Witzig R","year":"2006","unstructured":"Witzig R, Sch\u00f6nberger B, Fink U, et al.. Delays in diagnosis and therapy of gastric cancer and esophageal adenocarcinoma. Endoscopy. 2006, 38:1122-6. 10.1055\/s-2006-944847","journal-title":"Endoscopy"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-5691.21.08736-8","article-title":"Could diagnostic and therapeutic delay affect the prognosis of gastrointestinal primary malignancies in the COVID-19 pandemic era?","volume":"76","author":"DE Rosa M","year":"2021","unstructured":"DE Rosa M, Pasculli A, Rondelli F, et al.. Could diagnostic and therapeutic delay affect the prognosis of gastrointestinal primary malignancies in the COVID-19 pandemic era?. Minerva Surg. 2021, 76:467-76. 10.23736\/S2724-5691.21.08736-8","journal-title":"Minerva Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.228254","article-title":"Guidelines for the management of oesophageal and gastric cancer","volume":"60","author":"Allum WH","year":"2011","unstructured":"Allum WH, Blazeby JM, Griffin SM, Cunningham D, Jankowski JA, Wong R. Guidelines for the management of oesophageal and gastric cancer. Gut. 2011, 60:1449-72. 10.1136\/gut.2010.228254","journal-title":"Gut"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.14508","article-title":"Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma","volume":"1482","author":"Leng XF","year":"2020","unstructured":"Leng XF, Daiko H, Han YT, Mao YS. Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma. Ann N Y Acad Sci. 2020, 1482:213-24. 10.1111\/nyas.14508","journal-title":"Ann N Y Acad Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.12796","article-title":"Prognostic value of the number of negative lymph nodes in esophageal carcinoma without lymphatic metastasis","volume":"9","author":"Wu H","year":"2018","unstructured":"Wu H, Liu C, Xu M, Guo M, Xu S, Xie M. Prognostic value of the number of negative lymph nodes in esophageal carcinoma without lymphatic metastasis. Thorac Cancer. 2018, 9:1129-35. 10.1111\/1759-7714.12796","journal-title":"Thorac Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2152\/jmi.66.99","article-title":"Clinical outcomes and prognostic factors of definitive radiotherapy for esophageal cancer","volume":"66","author":"Tonoiso C","year":"2019","unstructured":"Tonoiso C, Ikushima H, Kubo A, et al.. Clinical outcomes and prognostic factors of definitive radiotherapy for esophageal cancer. J Med Invest. 2019, 66:99-105. 10.2152\/jmi.66.99","journal-title":"J Med Invest"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.55.9070","article-title":"Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction","volume":"32","author":"Davies AR","year":"2014","unstructured":"Davies AR, Gossage JA, Zylstra J, et al.. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction. J Clin Oncol. 2014, 32:2983-90. 10.1200\/JCO.2014.55.9070","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.2083","article-title":"Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer","volume":"27","author":"Allum WH","year":"2009","unstructured":"Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol. 2009, 27:5062-7. 10.1200\/JCO.2009.22.2083","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham D","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, et al.. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006, 355:11-20. 10.1056\/NEJMoa055531","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5761\/atcs.ra.16-00162","article-title":"Current status and future prospects for esophageal cancer treatment","volume":"23","author":"Sohda M","year":"2017","unstructured":"Sohda M, Kuwano H. Current status and future prospects for esophageal cancer treatment. Ann Thorac Cardiovasc Surg. 2017, 23:1-11. 10.5761\/atcs.ra.16-00162","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2017.1334764","article-title":"Current and future treatment options for esophageal cancer in the elderly","volume":"18","author":"Bollschweiler E","year":"2017","unstructured":"Bollschweiler E, Plum P, M\u00f6nig SP, H\u00f6lscher AH. Current and future treatment options for esophageal cancer in the elderly. Expert Opin Pharmacother. 2017, 18:1001-10. 10.1080\/14656566.2017.1334764","journal-title":"Expert Opin Pharmacother"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.29271\/jcpsp.2021.03.326","article-title":"CROSS or FLOT in distal esophageal and gastroesophageal cancer","volume":"31","author":"Karadag I","year":"2021","unstructured":"Karadag I, Karakaya S, Ates O, Cakmak Oksuzoglu OB. CROSS or FLOT in distal esophageal and gastroesophageal cancer. J Coll Physicians Surg Pak. 2021, 31:326-9. 10.29271\/jcpsp.2021.03.326","journal-title":"J Coll Physicians Surg Pak"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/86006-medical-oncology-or-surgical-oncology-which-branch-should-be-started-in-esophageal-cancer-diagnostic-evaluation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:45:59Z","timestamp":1707507959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/86006-medical-oncology-or-surgical-oncology-which-branch-should-be-started-in-esophageal-cancer-diagnostic-evaluation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.22286","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,16]]}}}